AngioDynamics, Inc. (ANGO)
Nasdaq: ANGO · Surgical & Medical Instruments & Apparatus · Latham, NY · filing with the SEC since 2004
Who owns AngioDynamics, Inc.
As filed with the SECHolders of 5% or more
4
Point72 Asset Management, L.P. holds 7.7% of Common Stock, par value $0.01 per share, as its SCHEDULE 13G/A filed May 15, 2026 says.
Directors and officers
14
report now, of 28 people on the record since 2006. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.01 per share · 6.2% in Nov 14, 2025
Blackrock, Inc.
SCHEDULE 13G/A · filed Apr 17, 2025 · Common Stock · 9.7% in Feb 5, 2025
Systematic Financial Management LP
SCHEDULE 13G · filed Feb 10, 2026 · Common Stock · 6.2% in Feb 13, 2025
Kevin Kotler
SCHEDULE 13G · filed Feb 9, 2026 · Common Stock, par value $.01
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $.01 · reported falling below 5%, from 5.16% in May 15, 2025
Millennium Management LLC
SCHEDULE 13G/A · filed Apr 14, 2025 · Common Stock, par value $0.01 per share · reported falling below 5%
Millennium Management LLC
SCHEDULE 13G/A · filed Jan 8, 2026 · Common Stock, par value $0.01 per share · reported falling below 5%, from 5.3% in Jul 22, 2025
Divisadero Street Capital Management, LP
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.01 · reported falling below 5%, from 8.4% in Aug 13, 2025
The Vanguard Group
SCHEDULE 13G/A · filed Mar 26, 2026 · Common Stock · reported falling below 5%
What ANGO reports owning in othersstakes of 5% or more, and other ties
8 subsidiaries in 8 countries, from the list filed with the 10-K filed Jul 14, 2026.
Insider tradesForm 4
3sales
0purchases
0sales on a scheduled plan
2people selling
$700,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Nov 4, 2025 to Nov 4, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 4, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Trowbridge Stephen A | EVP and CFO | 2 | $300,000 | 0 | 0 | $0 |
| Nighan Warren Jr | SVP Quality and Regulatory | 1 | $300,000 | 0 | 0 | $0 |